Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00177099 · ClinicalTrials.gov registry record · Phase 1
Effects of Ligands on Human Hair Follicles Grafted Onto SCID Mice
A Phase 1 study of Alopecia, sponsored by Hordinsky, Maria K., MD.
- Completed
- Registry status
- Phase 1
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT00177099: Completed Phase 1 study of Alopecia, sponsored by Hordinsky, Maria K., MD.
NCT00177099 is a Phase 1 study of Alopecia that has completed, run by Hordinsky, Maria K., MD. The registered enrollment target is 35 participants, below the 122-participant average among 13 other Alopecia trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00177099, a Phase 1 study of Alopecia, has completed, sponsored by Hordinsky, Maria K., MD.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if immunophilin ligands may have the potential to reverse hair loss.
Conditions Studied
Interventions
- DRUG FK506, GP11046, GP11511
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2003-07 |
| Est. Completion | 2004-09 |
| Phase | Phase 1 |
What the finished NCT00177099 record still lists
NCT00177099 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 122-participant average among 13 other Alopecia trials with a reported enrollment target (71% lower).
The record links to 1 condition, with Alopecia appearing as the primary indexed condition, and to 1 intervention - of which FK506, GP11046, GP11511 is the first listed.
NCT00177099 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT00177099 about?
NCT00177099 is a clinical study titled "Effects of Ligands on Human Hair Follicles Grafted Onto SCID Mice". The purpose of this study is to determine if immunophilin ligands may have the potential to reverse hair loss.
What is the current status of trial NCT00177099?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 35 participants. The study started on 2003-07. Estimated completion is 2004-09.
What conditions does trial NCT00177099 study?
This clinical trial studies the following conditions: Alopecia.
What interventions are being tested in trial NCT00177099?
The interventions under investigation include: FK506, GP11046, GP11511 (DRUG).
Who is sponsoring clinical trial NCT00177099?
This trial is sponsored by Hordinsky, Maria K., MD, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00177099 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alopecia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00177099's enrollment target sits among peer trials
35 9th of 13 higher than 5 of 13 other Alopecia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alopecia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Portable Scalp Cooling System (PSCS) to Prevent Hair Loss for Breast Cancer Patients (Cooler Heads)
RECRUITING · NA
-
Study Of Cold Cap Therapy For Prevention of Hairloss in Pediatric Patients Receiving Chemotherapy For Non-Malignant Indications and Solid Tumors
RECRUITING · NA
-
Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss
RECRUITING · NA
-
Scalp Cooling for Chemotherapy-Induced Alopecia in Patients of Color
RECRUITING · NA
-
Evaluation of Scalp Cooling During Chemotherapy on Quality of Life and the Potential Role of Single Nucleotide Variations on Chemotherapy-Induced Alopecia and Hair Regrowth in the Appalachian Highlands Region
RECRUITING · NA
-
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia